Insider Transactions in Q2 2024 at Insmed Inc (INSM)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
21,195
-16.65%
|
$1,271,700
$60.0 P/Share
|
|
Jun 10
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,195
+14.27%
|
$487,485
$23.75 P/Share
|
|
Jun 03
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
55,000
-33.59%
|
$3,025,000
$55.33 P/Share
|
|
Jun 03
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+15.11%
|
$1,045,000
$19.42 P/Share
|
|
May 30
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
21,195
-16.65%
|
$1,165,725
$55.0 P/Share
|
|
May 30
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,195
+14.27%
|
$487,485
$23.75 P/Share
|
|
May 29
2024
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
220,564
-65.25%
|
$11,028,200
$50.0 P/Share
|
|
May 29
2024
|
Sara Bonstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
220,564
+12.2%
|
$5,734,664
$26.26 P/Share
|
|
May 28
2024
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
44,722
-33.49%
|
$2,191,378
$49.53 P/Share
|
|
May 28
2024
|
Michael Alexander Smith Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,971
+6.12%
|
$506,623
$13.63 P/Share
|
|
May 28
2024
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,852
-3.09%
|
$384,748
$49.48 P/Share
|
|
May 28
2024
|
John Drayton Wise Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+4.66%
|
$75,000
$12.58 P/Share
|
|
May 28
2024
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,724
-5.78%
|
$1,036,200
$50.01 P/Share
|
|
May 28
2024
|
Sara Bonstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,724
+1.57%
|
$538,824
$26.26 P/Share
|
|
May 28
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
103,806
-49.45%
|
$5,086,494
$49.62 P/Share
|
|
May 28
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
103,806
+33.09%
|
$2,387,538
$23.66 P/Share
|
|
May 28
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
27,500
-20.18%
|
$1,347,500
$49.53 P/Share
|
|
May 28
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,500
+16.79%
|
$330,000
$12.58 P/Share
|
|
May 17
2024
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,945
-3.83%
|
$148,625
$25.09 P/Share
|
|
May 17
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,642
-4.19%
|
$116,050
$25.09 P/Share
|
|
May 14
2024
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,093
-5.11%
|
$127,325
$25.4 P/Share
|
|
May 14
2024
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,088
-3.96%
|
$127,200
$25.47 P/Share
|
|
May 14
2024
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,857
-4.82%
|
$196,425
$25.5 P/Share
|
|
May 14
2024
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,088
-8.62%
|
$277,200
$25.32 P/Share
|
|
May 14
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,640
-8.76%
|
$266,000
$25.47 P/Share
|
|
May 14
2024
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
22,198
-5.46%
|
$554,950
$25.52 P/Share
|
|
May 14
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
6,508
-5.65%
|
$162,700
$25.53 P/Share
|
|
May 13
2024
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,308
+11.78%
|
-
|
|
May 13
2024
|
John Drayton Wise Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,518
+10.16%
|
-
|
|
May 13
2024
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,518
+8.17%
|
-
|
|
May 13
2024
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,518
+10.15%
|
-
|
|
May 13
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,518
+10.68%
|
-
|
|
May 13
2024
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
42,707
+9.51%
|
-
|
|
May 13
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,308
+10.35%
|
-
|
|
May 13
2024
|
Clarissa Desjardins Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+17.52%
|
-
|
|
May 13
2024
|
Leo Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+9.55%
|
-
|
|
May 13
2024
|
David W J Mcgirr Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+11.74%
|
-
|
|
May 13
2024
|
Carol Schafer Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+18.43%
|
-
|
|
May 13
2024
|
Melvin Md Sharoky Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+4.1%
|
-
|
|
May 13
2024
|
David R Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+9.75%
|
-
|
|
May 13
2024
|
Alfred Altomari Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+15.92%
|
-
|
|
May 13
2024
|
Elizabeth M Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+16.08%
|
-
|